Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni D'Arena

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Leukemia & Lymphoma|September 21, 2018
Oxidative stress in chronic lymphocytic leukemia: still a matter of debateGiovanni D'Arena, Elisa Seneca, Ilaria Migliaccio, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 26, 2013
An urologic face of chronic lymphocytic leukemia: sequential prostatic and penis localizationGiovanni D'Arena, Roberto Guariglia, Oreste Villani, et al.
Oncotargets and Therapy|August 8, 2019
Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanismsAldo Giudice, Antonio Barbieri, Sabrina Bimonte, et al.
Leukemia|December 15, 2019
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
American Journal of Hematology|July 11, 2006
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemiaGiovanni D'Arena, Luca Laurenti, Silvana Capalbo, et al.
Blood|October 15, 2011
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathSara Serra, Alberto L Horenstein, Tiziana Vaisitti, et al.
Leukemia|August 31, 2019
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Oncotargets and Therapy|June 27, 2014
Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapyPellegrino Musto, Vittorio Simeon, Roberto Guariglia, et al.
Journal of Translational Medicine|February 1, 2012
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemiaPietro Bulian, Davide Rossi, Francesco Forconi, et al.
Haematologica|December 24, 2013
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphismRoberta Rizzo, Valentina Audrito, Paola Vacca, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Leukemia & Lymphoma|September 21, 2018
Oxidative stress in chronic lymphocytic leukemia: still a matter of debateGiovanni D'Arena, Elisa Seneca, Ilaria Migliaccio, et al.
Mediterranean Journal of Hematology and Infectious Diseases|January 26, 2013
An urologic face of chronic lymphocytic leukemia: sequential prostatic and penis localizationGiovanni D'Arena, Roberto Guariglia, Oreste Villani, et al.
Oncotargets and Therapy|August 8, 2019
Dissecting the prevention of estrogen-dependent breast carcinogenesis through Nrf2-dependent and independent mechanismsAldo Giudice, Antonio Barbieri, Sabrina Bimonte, et al.
Leukemia|December 15, 2019
Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
American Journal of Hematology|July 11, 2006
Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemiaGiovanni D'Arena, Luca Laurenti, Silvana Capalbo, et al.
Blood|October 15, 2011
CD73-generated extracellular adenosine in chronic lymphocytic leukemia creates local conditions counteracting drug-induced cell deathSara Serra, Alberto L Horenstein, Tiziana Vaisitti, et al.
Leukemia|August 31, 2019
Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implicationsFrancesca Arruga, Valeria Bracciamà, Nicoletta Vitale, et al.
Oncotargets and Therapy|June 27, 2014
Myelodysplastic disorders carrying both isolated del(5q) and JAK2(V617F) mutation: concise review, with focus on lenalidomide therapyPellegrino Musto, Vittorio Simeon, Roberto Guariglia, et al.
Journal of Translational Medicine|February 1, 2012
IGHV gene mutational status and 17p deletion are independent molecular predictors in a comprehensive clinical-biological prognostic model for overall survival prediction in chronic lymphocytic leukemiaPietro Bulian, Davide Rossi, Francesco Forconi, et al.
Haematologica|December 24, 2013
HLA-G is a component of the chronic lymphocytic leukemia escape repertoire to generate immune suppression: impact of the HLA-G 14 base pair (rs66554220) polymorphismRoberta Rizzo, Valentina Audrito, Paola Vacca, et al.
Pageof 10